Apoptosis of Human Neuroblastoma Cells Induced by Liposome-Encapsulated Fenretinide

References

• Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–1462
   PubMed Web of Science ®Google Scholar
• Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445–1449
   PubMed Web of Science ®Google Scholar
• Burek M.J., Oppenheim R.W. Programmed cell death in the developing nervous system. Brain Pathol 1996; 6: 427–446
   PubMed Web of Science ®Google Scholar
• Marx J. Cell death studies yield cancer clues. Science 1993; 259: 760–761
   PubMed Web of Science ®Google Scholar
• Dive C., Hickman J.A. Drug-target interactions: only the first step in the commitment to a programmed cell death. Br J Cancer 1991; 64: 192–196
   PubMed Web of Science ®Google Scholar
• Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957–967
   PubMed Web of Science ®Google Scholar
• Smith M.A., Parkinson D.R., Cheson B.D., Friedman M.A. Retinoids in cancer therapy. J Clin Oncol 1992; 10: 839–864
   PubMed Web of Science ®Google Scholar
• Smith M.A., Adamson P.C., Balis F.M., Feusner J., Aronson L., Murphy R.F., Horowitz M.E., Reaman G., Hammond G.D., Fenton R.M., Connagjan G.D., Hittelman W.N., Poplack D.G. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. J Clin Oncol 1992; 10: 1666–1673
   PubMed Web of Science ®Google Scholar
• Moon R.C., Thompson H.J., Becci P.J., Grubbs C.J., Gander R.J., Newton D.L., Smith J.M., Phillips S.L., Henderson W.R., Mullen L.T., Brown C.C., Sporn M.B. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 1979; 39: 1339–1346
   PubMed Web of Science ®Google Scholar
• Moon R.C., Mehta R.G., DetrisaC C.J. Retinois as chemopreventive agents for breast cancer. Cancer Res 1992; 39: 73–79
   Google Scholar
• Pollard M., Luckert P.H. The inhibitory effect of 4-hydroxyphenylreti-namide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats. Cancer Lett 1991; 59: 159–163
   Google Scholar
• Bhatnagar R., Abou-Issa H., Curley R.W., Jr, Koolemans-Beynen A., Moesch-Berger M. L., Webb T.E. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. Biochem Pharmacol 1991; 41: 1471–1472
   PubMed Web of Science ®Google Scholar
• Delia D., Aiello A., Lombardi L., Pelicci P.G., Grignani F., Grignani F., Grig-Nani F., Formelli F., Menard S., Costa A., Veronesi U., Pierotti M.A. N-(4- Hydroxyphenyl)retinamide (HPR) induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 1993; 53: 6036–6041
   PubMed Web of Science ®Google Scholar
• Supino R., Crosti M., Clerici M., Warlters A.S., Cleris L., Zunino F., Formelli F. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int J Cancer 1996; 65: 491–497
   PubMed Web of Science ®Google Scholar
• Kalemkerian G.P., Slusher R., Ramalingam S., Gadgeel S., Mabry M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst 1995; 87: 1674–1680
   PubMed Web of Science ®Google Scholar
• Ponzoni M., Bocca P., Chiesa V., Decensi A., Pistoia V., Raffaghello L., Rozzo C., Montaldo P.G. Differential effects of N-(4-Hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res 1995; 55: 853–861
   PubMed Web of Science ®Google Scholar
• Allen T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. TiPS 1994; 15: 215–220
   PubMed Web of Science ®Google Scholar
• Lasic D.D., Papahadjopoulos D. Liposomes revisited. Science 1995; 26: 1275–1276
   Google Scholar
• Lasic D.D. Doxorubicin in sterically stabilized liposomes. Nature 1996; 380: 561–562
   PubMed Web of Science ®Google Scholar
• Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivates of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochimica et Biophysica Acta 1991; 1066: 29–36
   PubMed Web of Science ®Google Scholar
• Szoka F., Papahadjopoulos D. Liposomes: preparation and characterization in Liposomes: From Physical Structure to Therapeutic Applications, C. G. Knigth. Elsevier/North-Holland Biomedical Press, Amsterdam/New York 1991
   Google Scholar
• Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973; 33: 2643–2652
   PubMed Web of Science ®Google Scholar
• Biedler J.L., Roffer-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38: 3751–3757
   PubMed Web of Science ®Google Scholar
• Tumilowicz J.J., Nichols W.W., Cholon J.J., Greene A. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 1970; 30: 2110–2118
   PubMed Web of Science ®Google Scholar
• Gross N., Beck D., Portoukalian J., Favre S., Carrel S. New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells. Int J Cancer 1989; 43: 665–671
   Google Scholar
• Matsushima H., Bogenmann E. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro. Int J Cancer 1992; 51: 250–258
   PubMedGoogle Scholar
• Longo L., Christiansen H., Christiansen N.M., Paulsen P., Comagli-Ferraris P., Lampert F. N-myc amplification at chromosome band lp32 in neuroblastoma cells as investigated by in situ hybridization. J Cancer Res Clin Oncol 1988; 114: 636–640
   Google Scholar
• Cornaglia-Ferraris P., Ponzoni M., Montaldo P., Mariottini G.L., Donti E., Di Martino D., Tonini G. A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-myc. Pediat Res 1990; 27: 1–6
   Google Scholar
• Cornaglia-Ferraris P., Sansone R., Mariottini G.L., Longo L., Tonini G. (b). Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line. Int J Cancer 1990; 45: 578–579
   Google Scholar
• Seeger R.C., Danon Y.L., Rayner S.A., Hoover F. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J Immunol 1982; 128: 983–989
   PubMed Web of Science ®Google Scholar
• Hultin T.A., Mehta R.G., Moon R.C. Simple high performance liquid chromatographic method for the separation of retinoids including N-(4-hydroxyphe-nyl)-all-trans-retinamide. J Chromatogr 1985; 341: 187–192
   Google Scholar
• Formelli F., Carsana R., Costa A., Buranelli F., Campa T., Dossena G., Magni A., Pizzichetta M. Plasma retinol level reduction by the synthetic retinoid Fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 1989; 49: 6149–6154
   PubMed Web of Science ®Google Scholar
• Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J., Raff M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365–369
   PubMed Web of Science ®Google Scholar
• Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Meth 1981; 145: 185–188
   Google Scholar
• Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139: 271–275
   PubMed Web of Science ®Google Scholar
• Formelli F., Clerici M., Campa T., Di Mauro M.G., Magni A., Mascotti G., Moglia D., De Palo G., Costa A. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 1993; 11: 2036–2042
   PubMed Web of Science ®Google Scholar
• Peng Y.M., Dalton W.S., Albberts D.S., Xu M.J., Lim H., Meyskens F.L., Jr. Pharmakinetics of N-4- hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int J Cancer 1989; 43: 22–26
   PubMed Web of Science ®Google Scholar
• Wyllie A.H., Kerr J F.R., Currie A.R. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251–306
   PubMedGoogle Scholar
• Chan L.-N., Zhang S., Shao J., Waikel R., Thompson E.A., Chan T.-S. N-(4-hydroxyphenyl) retinamide induces apoptosis in T lymphoma and T lymph-oblastoid leukemia cells. Leukemia and Lymphoma 1997; 25: 271–280
   PubMed Web of Science ®Google Scholar
• De Bernardi B., Rogers D., Carli M., Madon E., De Laurentis T., Bagnulo S., Di Tullio M., Paolucci G., Pastore G. Localized neuroblastoma. Cancer (Phila.) 1987; 60: 1066–1072
   PubMedGoogle Scholar
• Philip T., Ladenstein R., Zucker J.M., Pinkerton R., Bouffet E., Louis D., Siegert W., Bernard J.L., Frappaz D., Coze C., Wyss M., Beck D., Souillet G., Michon J., Philip I., Chauvin F., Favrot M., Biron P. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the Lmce2 study. Br J Cancer 1993; 67: 119–127
   PubMed Web of Science ®Google Scholar
• Pritchard J. Megatherapy for advanced neuroblastoma- Rationale and Role. Eur J Cancer 1995; 31 A: 134–136
   Google Scholar
• Garaventa A., Rondelli R., Lanino E., Dallorso S., Dini G., Bonetti F., Arrighini A., Santoro N., Rossetti F., Miniero R., Andolina M., Amici A., Indolfi P., Lo Curto M., Favre C., Paolucci P., Pession A., De Bernardi B. for the Italian Association of Pediatric Hematology- Oncology, BMT Group. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian bone marrow transplant Registry. Bone Marrow Transpl 1996; 18: 125–130
   PubMedGoogle Scholar
• D'Angio G.J., Evans A.E., Koop C.E. Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1971; 1: 1046–1049
   PubMed Web of Science ®Google Scholar
• Haas D., Ablin A.R., Miller C., Zoger S., Matthay K.K. Complete pathologic maturation and regression of stage IV-S neuroblastoma without treatment. Cancer 1988; 62: 818–825
   PubMedGoogle Scholar
• Hanada M., Krajewski S., Tanaka S., Cazals-Hatem D., Spengler B.A., Ross R.A., Biedler J.L., Reed J.C. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 1993; 53: 4978–4986
   PubMed Web of Science ®Google Scholar
• Goldstein P., Ojcius D.M., Young J.D. Cell death mechanisms and immune system. Immunol Rev 1991; 121: 29–65
   PubMed Web of Science ®Google Scholar
• Williams G.T. Programmed cell death: apoptosis and oncogenesis. Cell 1991; 65: 1097–1098
   PubMed Web of Science ®Google Scholar
• Gestblom C., Hoener J.C., Påhlman S. Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur J Cancer 1995; 31A: 458–463
   Google Scholar
• Moon R.C., Mehta R.G., Rao K.V. Retinoids and cancer in experimental animals in The retinoids: biology, chemistry, and medicine, M.B. Sporn, A.B. Roberts, D.S. Goodman. Raven Press, New York 1994; 573–596
   Google Scholar
• Modiano M.R., Dalton W.S., Lippman S.M., Joffe L., Booth A.R., Meyskens F.L., Jr. Phase II study of fenretinide (N-(4- Hydroxyphenyl)retinamide) in advanced breast cancer aand melanoma. Invest New Drugs 1990; 8: 17–19
   Google Scholar
• Fanjul A.N., Delia D., Pierotti M.A., Rideout D., Qiu J., Pfahl M. N-4-Hydroxyphenyl Retinamide is a highly selective activator of retinoid receptors. J Biol Chemiistry 1996; 271: 22441–22446
   PubMed Web of Science ®Google Scholar
• Yuan F., Leunig M, Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Microvascular permeability and interstitial penetration of sterically stabilizied (Stealth) liposomes in a human tumor xenograft. Cancer Res 1994; 54: 3352–3356
   PubMed Web of Science ®Google Scholar
• Wu Z.N., Da D., Rudoll T.L., Needham D., Whorton R., Dewhirst M.W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 1993; 53: 3765–3770
   PubMed Web of Science ®Google Scholar
• Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., Martin F. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994; 54: 987–992
   PubMed Web of Science ®Google Scholar
• Piacentini M., Annichiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J., Melino G. Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 1992; 52: 271–278
   PubMed Web of Science ®Google Scholar
• Montaldo P.G., Chiesa V., Bado M., Raffaghello L., Rozzo C., Ponzoni M. Induction of differentiation and apoptosis by interferon-γ in human neuroblastoma cells in vitro as a dual and alternative early biological response. Cell Death and Differentation 1997; 4: 150–158
   Google Scholar
• Chen J-Y, Clifford J., Zusi C., Starrett J., Tortolani D., Ostrowski J., Gronemeyer H. Two distinct actions of retinoid-receptor ligands. Nature 1996; 382: 819–822
   PubMed Web of Science ®Google Scholar
• Horn V., Minucci S., Ogryzko V.V., Adamson E.D., Howard B.H., Levin A.A., Ozato K. RAR and RXR selective lingands cooperatively induce apoptosis and neuronal differentation in P19 embryonal carcinoma cells. The Faseb J 1996; 10: 1071–1077
   PubMedGoogle Scholar
• Fanjul A.N., Bouterfa H., Pfahl M. Potential role of retinoic acird receptor-(in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res 1996; 56: 1571–1577
   PubMedGoogle Scholar
• Means A.L., Gudas L.J. The roles of retinoids in vertebrate development. Annu Rev Biochem 1995; 64: 201–233
   PubMed Web of Science ®Google Scholar